Poly Medicure Limited, established in 1995, is a manufacturer and marketer of medical devices. It is the largest exporter of medical devices in India and won several awards, including the Medical Device Company of the Year award in 2018 from the Indian government. Poly Medicure, headquartered in New Delhi, offers a range of medical devices which find application in infusion therapy, oncology, urology, dialysis, respiratory care, etc.
On 6 January 2022, the market capitalisation of the company was Rs 8,760.67 crore. It reported consolidated sales of Rs 879 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 531768 and the National Stock Exchange with the code POLYMED.
On 30 September 2022, the company’s shareholding pattern indicated a promoter stake of 53.3%, a 0% stake of foreign institutional investors, mutual funds and DIIs held a consolidated stake of 3.4%, and the public held a stake of 43.3% in the company. The company’s shareholding pattern has remained largely consistent over the past year.
The company’s board of directors comprises Devendra Raj Mehta, Himanshu Baid, Rishi Baid, Alessandro Balboni, Jugal Kishore Baid, Mukulika Baid, Amit Khosla, Prakash Chand Surana, Sandeep Bhargava, and others. The auditors are M C Bhandari & Co. On 30 September 2022, the company had a total of 9.59 crore shares outstanding.
On 6 January 2023, Poly Medicure’s share price on BSE was Rs 905.60 and Rs 905.1 on NSE. The share price touched a 52-week high of Rs 1,045.00 and a 52-week low of Rs 651.10. Its three-month return to investors was -4.12%, while its one-year return was -4.3%.
In November 2022, UTI Flexi Cap Direct-G invested Rs 240.2 crore in the company, while UTI Healthcare Direct-G and WhiteOak Capital Flexi Cap Fund invested Rs 12.9 and Rs 4.11 crore, respectively.
On November 2022, the company had a trailing 12 months (TTM) revenue of Rs 14,662 crore. The company also had a net profit of Rs 1,101 during the same period.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: firstname.lastname@example.org. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.